Key statistics
On Thursday, Oric Pharmaceuticals Inc (4TZ:STU) closed at 10.00, -32.89% below its 52-week high of 14.90, set on Mar 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.70 |
---|---|
High | 10.10 |
Low | 9.70 |
Bid | 9.95 |
Offer | 10.20 |
Previous close | 9.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 70.54m |
Free float | 64.10m |
P/E (TTM) | -- |
Market cap | 752.69m USD |
EPS (TTM) | -1.76 USD |
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
- ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates
- ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer
- ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
- ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
- ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
- ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
More ▼